Pre-existing immunity modulates responses to mRNA boosters

被引：21

作者：

Dangi, Tanushree ^{[1
]}

Sanchez, Sarah ^{[1
]}

Lew, Min Han ^{[1
]}

Awakoaiye, Bakare

Visvabharathy, Lavanya ^{[2
]}

Richner, Justin M. ^{[3
]}

Koralnik, Igor J. ^{[2
]}

Penaloza-MacMaster, Pablo ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA

[2] Northwestern Univ, Feinberg Sch Med, Ken & Ruth Davee Dept Neurol, Chicago, IL 60611 USA

[3] Univ Illinois, Dept Microbiol & Immunol, Coll Med, Chicago, IL 60612 USA

来源：

CELL REPORTS | 2023年 / 42卷 / 03期

关键词：

T-CELLS; VACCINE; EFFICACY; ANTIBODIES; CAPACITY;

D O I：

10.1016/j.celrep.2023.112167

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

mRNA vaccines are effective in preventing severe COVID-19, but breakthrough infections, emerging variants, and waning immunity warrant the use of boosters. Although mRNA boosters are being implemented, the extent to which pre-existing immunity influences the efficacy of boosters remains unclear. In a cohort of indi-viduals primed with the mRNA-1273 or BNT162b2 vaccines, we report that lower antibody levels before boost are associated with higher fold-increase in antibody levels after boost, suggesting that pre-existing antibody modulates the immunogenicity of mRNA vaccines. Our studies in mice show that pre-existing antibodies accelerate the clearance of vaccine antigen via Fc-dependent mechanisms, limiting the amount of antigen available to prime B cell responses after mRNA boosters. These data demonstrate a "tug of war"between pre-existing antibody responses and de novo B cell responses following mRNA vaccination, and they suggest that transient downmodulation of antibody effector function may improve the efficacy of mRNA boosters.

引用

页数：20

共 50 条

[41] Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers [J].

Gückel, B ;

Rentzsch, C ;

Nastke, MD ;

Marmé, A ;

Gruber, I ;

Stevanovic, S ;

Kayser, S ;

Wallwiener, D .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (04) :265-274

[42] Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 Patients [J].

Cugno, Massimo ;

Meroni, Pier Luigi ;

Consonni, Dario ;

Griffini, Samantha ;

Grovetti, Elena ;

Novembrino, Cristina ;

Torri, Adriana ;

Griffante, Gloria ;

Gariglio, Marisa ;

Varani, Luca ;

Peyvandi, Flora .

MICROORGANISMS, 2022, 10 (06)

[43] Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population [J].

Li, Min ;

Guo, Yaxin ;

Deng, Yao ;

Gao, Wenhui ;

Huang, Baoying ;

Yao, Weiyong ;

Zhao, Yingze ;

Zhang, Qing ;

Huang, Mengkun ;

Liu, Maoshun ;

Li, Lei ;

Guo, Peipei ;

Tian, Jinmin ;

Wang, Xin ;

Lin, Ying ;

Gan, Jinxian ;

Guo, Yuanyuan ;

Hu, Yuechao ;

Zhang, Jianing ;

Yang, Xiaonan ;

Shang, Bingli ;

Yang, Mengjie ;

Han, Yang ;

Wang, Yalan ;

Cong, Peilei ;

Li, Mengzhe ;

Chu, Qiaohong ;

Zhang, Danni ;

Wang, Qihui ;

Zhang, Tong ;

Wu, Guizhen ;

Tan, Wenjie ;

Gao, George F. ;

Liu, Jun .

CELL REPORTS, 2024, 43 (01)

[44] Pre-existing T Cell Memory against Zika Virus [J].

Schouest, Blake ;

Grifoni, Alba ;

Pham, John ;

Mateus, Jose ;

Sydney, John ;

Brien, James D. ;

De Silva, Aruna D. ;

Balmaseda, Angel ;

Harris, Eva ;

Sette, Alessandro ;

Weiskopf, Daniela .

JOURNAL OF VIROLOGY, 2021, 95 (12)

[45] Pre-existing Immunity to Norovirus GII-4 Virus-Like Particles Does Not Impair de Novo Immune Responses to Norovirus GII-12 Genotype [J].

Tamminen, Kirsi ;

Huhti, Leena ;

Vesikari, Timo ;

Blazevic, Vesna .

VIRAL IMMUNOLOGY, 2013, 26 (02) :167-170

[46] Aspirin for the prevention of pre-eclampsia in women with pre-existing diabetes: Systematic review [J].

Zen, Monica ;

Haider, Rabbia ;

Simmons, David ;

Peek, Michael ;

Nolan, Christopher J. ;

Padmanabhan, Suja ;

Jesudason, Shilpa ;

Alahakoon, Thushari, I ;

Cheung, Ngai Wah ;

Lee, Vincent W. .

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2022, 62 (01) :12-21

[47] Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity [J].

Ilett, E. J. ;

Prestwich, R. J. ;

Kottke, T. ;

Errington, F. ;

Thompson, J. M. ;

Harrington, K. J. ;

Pandha, H. S. ;

Coffey, M. ;

Selby, P. J. ;

Vile, R. G. ;

Melcher, A. A. .

GENE THERAPY, 2009, 16 (05) :689-699

[48] Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines [J].

Altenburg, Arwen F. ;

van Trierum, Stella E. ;

de Bruin, Erwin ;

de Meulder, Dennis ;

van de Sandt, Carolien E. ;

van der Klis, Fiona R. M. ;

Fouchier, Ron A. M. ;

Koopmans, Marion P. G. ;

Rimmelzwaan, Guus F. ;

de Vries, Rory D. .

SCIENTIFIC REPORTS, 2018, 8

[49] Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients [J].

Xagara, Anastasia ;

Goulielmaki, Maria ;

Fortis, Sotirios P. ;

Kokkalis, Alexandros ;

Chantzara, Evangelia ;

Christodoulopoulos, George ;

Samaras, Ioannis ;

Saloustros, Emmanouil ;

Tsapakidis, Konstantinos ;

Papadopoulos, Vasileios ;

Pateras, Ioannis S. ;

Georgoulias, Vasilis ;

Baxevanis, Constantin N. ;

Kotsakis, Athanasios .

CANCERS, 2024, 16 (13)

[50] Retargeting pre-existing human antibodies to a bacterial pathogen with an alpha-Gal conjugated aptamer [J].

Kristian, Sascha A. ;

Hwang, John H. ;

Hall, Bradley ;

Leire, Emma ;

Iacomini, John ;

Old, Robert ;

Galili, Uri ;

Roberts, Charles ;

Mullis, Kary B. ;

Westby, Mike ;

Nizet, Victor .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2015, 93 (06) :619-631

← 1 2 3 4 5 →